We previously demonstrated that quantification of Krebs cycle metabolites in tumor tissue can classify PPGLs and identify tumors with underlying alteration in SDH-genes (SDHx), FH, and IDH-genes (IDHx) and can furthermore aid in classification of variants of unknown significance in SDHx [21,23]. This evidence concerns the gene SDHB and neoplasm.